References
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase. International Agency for Research on Cancer; 2013. [cited 2014 Sep 20].
- Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347–65.
- Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 2007;370: 765–73.
- Hansen JG, Pedersen L, Overvad K, Omland Ø, Jensen HK, Sørensen HT. The Prevalence of chronic obstructive pulmonary disease among Danes aged 45–84 years: Population-based study. COPD 2008;6:347–52.
- Grose D, Morrison DS, Devereux G, Jones R, Sharma D, Selby C, et al. Comorbidities in lung cancer: Prevalence, severity and links with socioeconomic status and treatment. Postgrad Med J 2014;90:305–10.
- Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 2009;34:380–86.
- Luchtenborg M, Jakobsen E, Krasnik M, Linklater KM, Mellemgaard A, Moller H. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Eur J Cancer 2012;48:3386–95.
- Boje CR, Dalton SO, Gronborg TK, Primdahl H, Kristensen CA, Andersen E, et al. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: A population based study from the DAHANCA database. Acta Oncol 2013;52:285–93.
- Asmis TR, Ding K, Seymour L, Shepherd FA, Leigh NB, Winton TL, et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: A review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 2008;26:54–9.
- Putila J, Guo NL. Combining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancer. PLoS One 2014;9:e100994.
- Lee SJ, Lee J, Park YS, Lee CH, Lee SM, Yim JJ, et al. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer. J Thorac Oncol 2014;9:812–7.
- COPD Assessment Test. [cited 2014 Sep 20]. Available from: http://www.catestonline.org/.
- Fayersa P, Bottomleyc A. Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer 2002;38: 125–33.
- Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, et al. Minimum clinically important difference for the COPD Assessment Test: A prospective analysis. Lancet Respir Med 2014;2:195–203.
- Global Strategy for Diagnosis, Management and Prevention of COPD 2014, © Global Initiative for Chronic Obstructive Lung Disease (GOLD), all rights reserved. Available from http://www.goldcopd.org/
- Cavaillès A, Brinchault-Rabin G, Dixmier A, Goupil F, Gut-Gobert C, Marchand-Adam S, et al. Comorbidities of COPD. Eur Respir Rev 2013;22:454–75. Accessed on 15th November, 2014.